Showing results (221-230 of 229) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 229 results.
International Journal of Molecular Sciences|May 27, 2023
Evidence for Angiotensin II as a Naturally Existing Suppressor for the Guanylyl Cyclase A Receptor and Cyclic GMP GenerationXiao Ma, Seethalakshmi R Iyer, Xiaoyu Ma, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
EVIDENCE FOR ANGIOTENSIN II AS A NATURALLY EXISTING SUPPRESSOR FOR THE NATRIURETIC PEPTIDE SYSTEMXiao Ma, Seethalakshmi R Iyer, Xiaoyu Ma, et al.
Plos One|July 28, 2017
Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcomaPeter Y Yu, Heather L Gardner, Ryan Roberts, et al.
Molecular Cancer Therapeutics|January 25, 2023
Redundant Signaling as the Predominant Mechanism for Resistance to Antibodies Targeting the Type-I Insulin-Like Growth Factor Receptor in Cells Derived from Childhood SarcomaTerry J Shackleford, Seethalakshmi Hariharan, Angelina V Vaseva, et al.
Medical Education Online|September 27, 2024
Accelerated 3YMD programs: the last decade of growth of the Consortium of Accelerated Medical Pathway Programs (CAMPP)Catherine L Coe, Sally A Santen, Annette C Reboli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Antitumor Activity of a Mitochondrial-Targeted HSP90 Inhibitor in GliomasShiyou Wei, Delong Yin, Shengnan Yu, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomasSeethalakshmi Hariharan, Benjamin T Whitfield, Christopher J Pirozzi, et al.
Nature Communications|January 25, 2024
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomasSeethalakshmi Hariharan, Benjamin T Whitfield, Christopher J Pirozzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2021
A Modified Nucleoside 6-Thio-2'-Deoxyguanosine Exhibits Antitumor Activity in GliomasShengnan Yu, Shiyou Wei, Milan Savani, et al.
Pageof 23